Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
C Cordonnier, S Einarsdottir, S Cesaro… - The Lancet infectious …, 2019 - thelancet.com
Infection is a main concern after haemopoietic stem cell transplantation (HSCT) and a major
cause of transplant-related mortality. Some of these infections are preventable by …
cause of transplant-related mortality. Some of these infections are preventable by …
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
Background Immunocompromised (IC) patients are at higher risk of severe SARS-CoV-2
infection, morbidity, and mortality compared to the general population. They should be …
infection, morbidity, and mortality compared to the general population. They should be …
Suboptimal response to coronavirus disease 2019 messenger RNA vaccines in patients with hematologic malignancies: a need for vigilance in the postmasking era
ME Agha, M Blake, C Chilleo, A Wells… - Open forum infectious …, 2021 - academic.oup.com
We measured severe acute respiratory syndrome coronavirus 2 immunoglobulin G
responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine …
responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine …
[HTML][HTML] Safety and tolerability of SARS-CoV2 emergency-use authorized vaccines for allogeneic hematopoietic stem cell transplant recipients
The safety and efficacy of the severe acute respiratory syndrome coronavirus-2 (SARS-
CoV2) emergency-use authorized (EUA) vaccines have been confirmed in the general …
CoV2) emergency-use authorized (EUA) vaccines have been confirmed in the general …
Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients
N Shem‐Tov, R Yerushalmi, I Danylesko… - British Journal of …, 2022 - Wiley Online Library
The immunogenicity and safety of Pfizer‐BioNTech BNT162b2 mRNA vaccine in allogeneic
haematopoietic stem cell transplantation (HSCT) recipients are unknown. We prospectively …
haematopoietic stem cell transplantation (HSCT) recipients are unknown. We prospectively …
Influenza vaccines in immunosuppressed adults with cancer
R Bitterman, N Eliakim‐Raz, I Vinograd… - Cochrane Database …, 2018 - cochranelibrary.com
Objectives To assess the effectiveness of influenza vaccine in immunosuppressed adults
with malignancies. The primary review outcome is all‐cause mortality, preferably at the end …
with malignancies. The primary review outcome is all‐cause mortality, preferably at the end …
Vaccine-preventable infections among solid organ transplant recipients in Switzerland
Importance Vaccine responses are decreased in solid organ transplant (SOT) recipients,
and given the complexity of implementation, vaccination programs may be suboptimal. The …
and given the complexity of implementation, vaccination programs may be suboptimal. The …
[HTML][HTML] Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients
ABSTRACT Coronavirus disease 2019 (COVID-19), a respiratory illness caused by the
novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a …
novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a …
Seasonal influenza vaccine in immunocompromised persons
Immunocompromised persons are at high risk of complications from influenza infection. This
population includes those with solid organ transplants, hematopoietic stem cell transplants …
population includes those with solid organ transplants, hematopoietic stem cell transplants …
[HTML][HTML] Analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States
Increasing use of immunosuppressive biologic therapies poses a challenge for infectious
diseases. Immunosuppressed patients have a high risk for influenza complications and an …
diseases. Immunosuppressed patients have a high risk for influenza complications and an …